Pharmacological reviewsHumansDrug DiscoveryArtificial IntelligenceAnimals
Leading artificial intelligence-driven drug discovery platforms: 2025 landscape and global outlook.
Mahendiran Dharmasivam, Busra Kaya, Adedoyin Akinware, Mahan Gholam Azad, Des R Richardson
Published: 202610.1016/j.pharmr.2025.100102
Abstract
Artificial intelligence (AI) has progressed from experimental curiosity to clinical utility, with AI-designed therapeutics now in human trials across diverse therapeutic areas. This review critically compares 5 leading AI-driven discovery platforms:…
Preview only. Read the full abstract at the source